A sarcoidosis patient and ardent supporter of the Foundation for Sarcoidosis Research (FSR) was dubbed a “warrior” by…
Mary Chapman
Mary graduated from Wayne State University with a degree in journalism. She began her career at United Press International, then spent a decade reporting for the Bureau of National Affairs, Inc. (now Bloomberg Industry Group). Mary has written extensively for The New York Times, and her work has appeared in publications such as Time, Newsweek, Fortune, and the Chicago Tribune. She’s won a Society of Professional Journalists award for outstanding reporting.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Mary Chapman
Saying “sarcoidosis” can be problematic for some, so the Foundation for Sarcoidosis Research (FSR) will focus on the condition’s…
To help boost awareness of sarcoidosis and support those affected by the complex and often misunderstood disorder, the…
The Foundation for Sarcoidosis Research (FSR) is offering ways to participate in National Sarcoidosis Awareness Month, observed each April,…
Four sarcoidosis patients and researchers who work to better understand the disease and raise awareness about it will be honored…
The Ann Theodore Foundation and the Milken Institute have awarded more than $3 million to six research teams nationwide to…
Temple Lung Center at Temple Health in Philadelphia has become a founding member of the Foundation for Sarcoidosis Research (FSR)…
The National Organization for Rare Disorders’ (NORD) “Living Rare, Living Stronger Patient and Family Forum” is back in person…
The Foundation for Sarcoidosis Research (FSR) has introduced a new online support group for those with chronic sarcoidosis.
Two university professors have each been awarded $25,000 small research grants from the Foundation for Sarcoidosis Research (FSR) to…